UCLA Cannabis Research Initiative Launches COVID-19 Survey
The social and economic impacts of the COVID-19 pandemic, coupled with high rates of infection has had an unprecedented effect on mental health. A recent CDC survey found that more than 4 in 10 Americans are struggling with pandemic-related mental health issues, including increased substance use.
“It’s hypothesized that recreational cannabis, medical cannabis and CBD (cannabidiol) use has changed due to COVID-19 for a number of reasons including self-medication for mental health conditions,” said Ziva Cooper, PhD, interim director and research director of the Cannabis Research Initiative. “The objective of this U.S.-based anonymous survey is to understand if and why cannabis and CBD use has changed.”
The survey will:
- Explore whether people who use recreational and medical cannabis have changed the way they use it to reduce the pulmonary risk associated with inhalation (vaporizing or smoking).
- Investigate if and how medical cannabis and CBD use has changed for mental health conditions (anxiety, insomnia, depression) associated with COVID-19.
- Seek to understand if cannabis use (frequency and method of use) changed in people with suspected or confirmed cases of COVID-19.
- Are people using more cannabis and CBD because they are more anxious, depressed or have more insomnia than before the pandemic?
- If people are still using inhaled cannabis, are they still sharing joints and vapes with others?
- Has the pandemic raised concerns among users about the pulmonary risks associated with inhaling cannabis?
- Are people using CBD as a preventative against COVID-19 infections?
Source: UCLA Health